Edmund Dunn

Principal Accounting Officer, Monte Rosa Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.5M

Companies

Latest trade

Mar 4, 2026

Companies

Monte Rosa Therapeutics, Inc.Principal Accounting Officer −$0.5M

Trades

GLUE Sold 139 shares at $17.96 $0.0M Mar 4

GLUE Sold 536 shares at $17.50 $0.0M Mar 2

GLUE Sold 25,164 shares at $18.10 $0.5M Feb 27

GLUE Sold 1,039 shares at $15.17 $0.0M Jan 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.